| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 1998-01-01 |
Cell Pathways, Inc.
Life Science Horsham, Pennsylvania Cell Pathways, Inc develops and commercializes drugs for the prevention and treatment of cancer. |
IPO
|
- |
Northwood Ventures
|
||
| 2013-05-31 |
Epizyme
Life Science Cambridge, Massachusetts www.epizyme.com Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme was founded in 2007 and is based in Cambridge, Massachusetts. |
PIPE |
Bay City Capital
|
Bay City Capital
|
||
| 1996-02-01 |
Shire plc
Life Science Dublin, Ireland www.shire.com Shire plc is a global specialty biopharmaceutical company. Shire plc strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest. |
IPO | - |
Permira
EW Healthcare Partners
|
||
| 2012-10-26 |
Athersys
Life Science Cleveland, Ohio www.athersys.com Athersys is a clinical-stage bio-pharmaceutical company, discovery and development of therapeutic products in various disease areas. Athersys was founded in 1995 and is based in Cleveland, Ohio. |
IPO | - |
Primus Capital
|
||
| 2007-06-01 |
Jazz Pharmaceuticals
Life Science Dublin, Ireland www.jazzpharma.com Jazz Pharmaceuticals is a specialty biopharmaceutical company that identifies, develops, and commercializes products to address unmet medical needs in focused therapeutic areas. Jazz Pharmaceuticals was founded in 2003 and is based in Dublin, Ireland. |
IPO | - |
BPOC
Adams Street Partners
KKR
EGS Healthcare Capital Partners
Golden Gate Capital
Waud Capital Partners
Cressey & Company
|
||
| 2004-03-26 |
Myogen, Inc.
Life Science Westminster, Colorado www.myogen.com Myogen is a Development stage biotechnology company focused on cardiovascular drugs. Myogen has two product candidates in late-stage clinical development: ambrisentan for the treatment of patients with pulmonary arterial hypertension (PAH) and darusentan for the treatment of patients with resistant hypertension. |
IPO | - |
Aisling Capital
Adams Street Partners
|
||
| 2013-09-05 |
IQVIA
Life Science Durham, North Carolina www.iqvia.com IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA is based in Durham, North Carolina. |
IPO | - |
Aisling Capital
TPG
Bain Capital Private Equity
3i Private Equity
|
||
| 2010-11-23 |
Zogenix
Life Science Emeryville, California www.zogenix.com Zogenix is a pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. Zogenix was founded in 2006 and is based in Emeryville, California. |
IPO | - |
Chicago Growth Partners LLC
|
||
| 2005-11-01 |
Zalicus, Inc.
Life Science Cambridge, Massachusetts www.zalicus.com Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and inflammation. |
IPO | - |
Adams Street Partners
Easton Capital Investment Group
|
||
| 2014-07-01 |
GlobeImmune
Life Science Louisville, Colorado globeimmune.com GlobeImmune is a biopharmaceutical company that focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. GlobeImmune was founded in 1995 and is headquartered in Louisville, Colorado. |
IPO | - |
Adams Street Partners
|
||
| 2014-11-07 |
Syneos Health
Life Science Morrisville, North Carolina www.syneoshealth.com Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina. |
IPO | - |
Avista Healthcare Partners
Ontario Teachers Pension Plan
The Carlyle Group
|
||
| Deal Link | ||||||
| 2014-03-03 |
Corium
Life Science Boston, Massachusetts www.corium.com Corium is a commercial-stage biopharmaceutical company focused on the development, manufacture, and commercialization of specialty pharmaceutical products that leverage the company’s broad experience with advanced transdermal and transmucosal delivery systems. Corium was founded in 1995 and is based in Boston, Massachusetts. |
IPO | - |
EW Healthcare Partners
|
||
| 2009-11-19 |
Global Cord Blood
Life Science Hong Kong, China www.globalcordbloodcorp.com Global Cord Blood is a provider of umbilical cord blood storage and ancillary services. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. Global Cord Blood was founded in 2006 and is based in Hong Kong, China. |
IPO | - |
EW Healthcare Partners
|
||
| 1995-11-30 |
Parexel
Life Science Durham, North Carolina www.parexel.com Parexel is a global provider of clinical research and consulting services to the pharma and biotech industry. Parexel’s services enable the development of innovative new medicines that improve the health of patients across the world. Parexel was founded in 1983 and is based in Durham, North Carolina. |
IPO | - |
Capvis
|
||
| 2014-07-31 |
Catalent
Life Science Somerset, New Jersey www.catalent.com Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey. |
IPO | - |
Genstar Capital
The Blackstone Group
Aisling Capital
|
||
| 2007-07-24 |
Cumberland Pharmaceuticals
Life Science Nashville, Tennessee www.cumberlandpharma.com Cumberland Pharmaceuticals is a pharmaceutical company that acquires and develops branded prescription products primarily in the gastroenterology, critical care and infection control areas. Cumberland Pharmaceuticals was founded in 1999 and is based in Nashville, Tennessee. |
IPO | - |
Greer Capital Advisors
|
||
| Avg |
$32
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
